Edrecolomab (intravenous injection; 30 μg/dose; day 1, 4 and 7 after tumor-cell inoculation) treatment inhibits tumor growth in the HT-29 nude mouse model[1].
| Animal Model: | Male nu/nu mice injected with HT-29 colon carcinoma cells[1] |
| Dosage: | 30 μg/dose |
| Administration: | Intravenous injection; 30 μg/dose; day 1, 4 and 7 after tumor-cell inoculation |
| Result: | Inhibited tumor growth with a number of significant readings (p≤0.05). |
